Irritable Bowel Syndrome with Constipation
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: Mode of Action of Moviprep [Phase 4]
A Phase 4 clinical trial investigating the mode of action of Moviprep in functional constipation and IBS with constipation has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation [Phase 3]
Phase 3 trial update on Lubiprostone for irritable bowel syndrome with constipation, including efficacy and safety results.
-
FDA approval · 2013-08-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2013-08-08FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., resulting in an updated labeling or indication fo…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation [Phase 2]
Phase 2 study evaluating the effectiveness of itopride hydrochloride in irritable bowel syndrome with constipation; the trial is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 3]
Phase 3 trial of linaclotide in irritable bowel syndrome with constipation completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation [Phase 3]
Phase 3 trial of linaclotide in irritable bowel syndrome with constipation has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]
A randomized, double-blind, Phase 2 dose-range-finding study evaluated linaclotide for irritable bowel syndrome with constipation; results w…
-
FDA approval · 2012-11-26FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories.
-
FDA approval · 2012-08-30FDA Approved: LINZESS — Original Application (Allergan, Inc.)
The FDA approved Linzess (linaclotide) through its Original Application by Allergan, establishing its use for adults with irritable bowel sy…
-
CLINICAL_TRIALS withdrawal · 2010-11-18Clinical Trial Update: A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Clinical trial update indicating the tegaserod tIND program in women with irritable bowel syndrome with constipation or chronic idiopathic c…
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Constipation Associated With Irritable Bowel Syndrome (IBS-C) [Phase 3]
A Phase 3 trial evaluating constipation in irritable bowel syndrome with constipation (IBS-C) has completed.
-
FDA approval · 2008-04-29FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc., indicating an update to the product lab…
-
CLINICAL_TRIALS trial_result · 2008-04-08Clinical Trial Update: A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females [Phase 2, Phase 3]
This clinical trial update concerns the Phase 2/Phase 3 study of DDP733 for irritable bowel syndrome with constipation in females. The curre…
-
CLINICAL_TRIALS trial_result · 2008-01-28Clinical Trial Update: Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS [Phase 4]
Phase 4 trial results evaluating the efficacy of Tegaserod in relieving symptoms of irritable bowel syndrome in women, including IBS with co…
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c [Phase 2]
A Phase 2 trial evaluating the safety, tolerability, and pharmacodynamics of DDP733 for irritable bowel syndrome with constipation has compl…